Literature DB >> 8647053

Antiepileptic drug therapy: when is epilepsy truly intractable?

P R Camfield1, C S Camfield.   

Abstract

We define intractable in the first 5 years of epilepsy treatment as an average of at least one seizure every 2 months. For the longer term, we define intractable as at least one seizure per year. Population studies from Chicago, IL, U.S.A., Finland, and Nova Scotia, Canada indicate that with long follow-up, many children with intractable epilepsy eventually have remission of their seizure disorder. Epilepsy is no longer intractable when the seizures stop completely. How often does a new antiepileptic drug (AED) render a child seizure-free when one or more AEDs have failed? Literature on adults with epilepsy suggests that few with chronic epilepsy who have not achieved seizure control with several AEDs will achieve complete seizure control with additional AEDs. The Nova Scotia study suggests that if a child's seizure fails to be controlled with a first AED, there is an increased risk of intractable epilepsy. Nonetheless, the chance of eventual, complete remission of epilepsy (seizure-free without AED treatment) is approximately 40%. We conclude that intractability should not be considered until there has been failure of at least three first-line AEDs. Intractable epilepsy is rare. Careful definition of the characteristics of children with intractable epilepsy who do respond completely to new AEDs will likely provide the only rational approach to treatment of children with three drug failures. Collaboration by multiple epilepsy centers will be required to gain this information.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647053     DOI: 10.1111/j.1528-1157.1996.tb06023.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  9 in total

Review 1.  Early epilepsy surgery.

Authors:  Samuel Wiebe
Journal:  Curr Neurol Neurosci Rep       Date:  2004-07       Impact factor: 5.081

2.  Purines and the Anti-Epileptic Actions of Ketogenic Diets.

Authors:  Susan A Masino; Masahito Kawamura; David N Ruskin; Jeremy Gawryluk; Xuesong Chen; Jonathan D Geiger
Journal:  Open Neurosci J       Date:  2010-01-01

Review 3.  Pediatric epilepsy surgery.

Authors:  Anuj Jayakar; Jeffrey Bolton
Journal:  Curr Neurol Neurosci Rep       Date:  2015-06       Impact factor: 5.081

Review 4.  Advances in neuroimaging: non-substrate-directed partial epilepsy.

Authors:  S Tigaran; T J O'Brien; G D Cascino
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

Review 5.  The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect.

Authors:  Marc Yudkoff; Yevgeny Daikhin; Torun Margareta Melø; Ilana Nissim; Ursula Sonnewald; Itzhak Nissim
Journal:  Annu Rev Nutr       Date:  2007       Impact factor: 11.848

Review 6.  Melatonin as add-on treatment for epilepsy.

Authors:  Francesco Brigo; Stanley C Igwe; Alessandra Del Felice
Journal:  Cochrane Database Syst Rev       Date:  2016-08-11

7.  Surgery for childhood epilepsy.

Authors:  Sita Jayalakshmi; Manas Panigrahi; Subrat Kumar Nanda; Rammohan Vadapalli
Journal:  Ann Indian Acad Neurol       Date:  2014-03       Impact factor: 1.383

8.  Expression of Circ_Satb1 Is Decreased in Mesial Temporal Lobe Epilepsy and Regulates Dendritic Spine Morphology.

Authors:  Andreia Gomes-Duarte; Morten T Venø; Marina de Wit; Ketharini Senthilkumar; Mark H Broekhoven; Joëlle van den Herik; Fleur R Heeres; Daniëlle van Rossum; Mateja Rybiczka-Tesulov; Ivano Legnini; Peter C van Rijen; Pieter van Eijsden; Peter H Gosselaar; Nikolaus Rajewsky; Jørgen Kjems; Vamshidhar R Vangoor; R Jeroen Pasterkamp
Journal:  Front Mol Neurosci       Date:  2022-03-03       Impact factor: 5.639

9.  Response to Early AED Therapy and Its Prognostic Implications.

Authors:  Jacqueline A. French
Journal:  Epilepsy Curr       Date:  2002-05       Impact factor: 7.872

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.